CpG dinucleotides provide hotspots for transitional mutations in a variety of genes, some leading to genetic diseases in humans. Although this phenomenon is attributed to cytosine methylation at such sites, direct and specific observations of CpG methylation at the sites of recurrent mutations are lacking. We have used a bisulfite genomic sequencing method to analyze DNA methylation within three representative exons from the neurofibromatosis type 1 (NF1) gene, well recognized for its high frequency of spontaneous mutations. We observed that the cytosine methylation within NF1 exons 28, 29, and 31 is restricted to CpG dinucleotides, including the CpG dinucleotide present at the site of the recurrent NF1 mutation (C5839T; also referred to as R1947X). At several sites, clone-specific methylation differences were also observed. Our results provide experimental evidence for the hypothesis that methylatable CpGs in the NF1 gene contribute to spontaneous germline mutations associated with this gene, by showing that DNA methylation does occur at all CpGs contained within these representative NF1 exons. As well, the DNA methylation seen at the common mutation site in exon 31 may explain why this site is frequently mutated. Methylation-dependent mutagenesis may also provide a basis for some somatic (second hit) mutations which disable the normal allele and result in the development of NF1 associated symptoms.
INTRODUCTION
The epigenetic modification of eukaryotic DNA by the methylation of cytosine residues modulates access to and regulation of, genetic information (1) . This process is implicated in the regulation of gene expression, oncogenesis, imprinting and X-inactivation. As well, DNA methylation is thought to be a major contributor of point mutations leading to human genetic disease, when it precedes deamination of 5-methylcytosine ( m5 C) present within CpG dinucleotides (2, 3) . CpG dinucleotides are hypothesized to be a hotspot for mutations in a variety of genes, where a substantial proportion of intragenic single base-pair mutations (35%) occur in CpG dinucleotides and are the result of C!T or G!A transitions (3) . Consequently, the rate of transitions at CpGs is suggested to be 20-fold higher than transitions at non-CpG sites (2, 4) . Few studies have assessed DNA methylation in coding regions experimentally, although in the p53 gene, DNA sequences within exons 5-8 have been shown to be completely methylated at every CpG site, including 46 different sites on both DNA strands (5) .
We have hypothesized that DNA methylation contributes to the high frequency of mutations in the NF1 gene causing neurofibromatosis type 1 (6) . This autosomal dominant disease is common in most populations (7) and the NF1 gene is localized to chromosome 17q11.2 (8) . Over 90% of spontaneous mutations are attributed to the paternal genome (9, 27) and the majority are heterogeneous in nature (10) . While no common high frequency mutation has been identified in this gene, a transitional mutation at one particular CpG dinucleotide (C5839T; also referred to as R1947X) has been characterized in a number of unrelated patients with this disease (10, (24) (25) (26) . In a previous paper we described our analysis of DNA methylation patterns in areas flanking the NF1 gene and within the coding region of the gene itself (6) . Our experiments relied on the use of methylation-sensitive restriction enzymes in combination with Southern blotting and PCR-based techniques to identify methylated -CCGG-motifs (recognized by the restriction enzymes MspI and HpaII). We were able to show that several CpG dinucleotides contained within MspI/HpaII sites were indeed methylated. However, the techniques that were used limited our ability to assess site-specific methylation along a continuous stretch of DNA.
In the present study we have used a bisulfite genomic sequencing method (11) to evaluate DNA methylation at all cytosines including CpG dinucleotides within three representative exons from the large (8.5 kb) NF1 coding region. In this method, the difference between cytosines and 5-methylcytosines is identified by differences in their reactivity to sodium bisulfite. This highly specific chemical reaction permits methylation status to be determined for each cytosine residue on individual DNA strands that have been amplified from any target template (11) (12) (13) . In this protocol, total genomic DNA is denatured and then treated with sodium bisulfite, causing the deamination of cytosines and creating uracil residues. Any 5-methylcytosine residues, however, remain unreacted. PCR amplification of the treated genomic DNA yields a fragment of interest in which all the uracil (formerly unmethylated cytosine) residues are amplified as thymine, while only 5-methylcytosine residues are amplified as cytosines. The amplified, converted DNA fragments then can be cloned and sequenced, and the methylation status of all CpGs within the DNA fragment can be established. The results can be used to evaluate tissue-specific or allele-specific DNA methylation at mutational hotspots with the goal of establishing a role for DNA methylation in expression and site-specific mutagenesis.
Our results on representative exons of the NF1 gene suggest that DNA methylation is almost exclusively restricted to cytosine residues within CpG dinucleotides located in these exons. Almost all CpGs available for evaluation undergo methylation to different degrees. In particular, we have found that the CpG dinucleotide in exon 31 where the only known recurrent NF1 mutation (C5839T; R1947X) occurs is shown to undergo DNA methylation.
RESULTS
Total genomic DNA from placenta, sperm and blood lymphocytes was denatured with sodium bisulfite, then the bisulfite-converted genomic DNA was amplified with PCR primers specific to exons 28, 29 and 31 of the NF1 gene. The amplified DNA fragments were cloned using the TA cloning system (Invitrogen, San Diego, Ca) and sequenced so that the methylation status of all cytosines residues (including those within CpG dinucleotides) could be established. Unmethylated cytosines are defined by the absence of the band in the 'C' lane of the sequencing gel and its presence in the 'T' lane. A methylated cytosine would be retained in its appropriate position in the 'C' lane of the gel.
We found that DNA methylation within NF1 exons 28 ( Fig. 1 ) and 29 ( Fig. 2) and 31 (Fig. 3) is almost exclusively restricted to CpG dinucleotides. In each exon 28 clone, six CpG dinucleotides and 48 non-CpG cytosines were analyzed by sequencing of the modified DNA (Fig. 1) . The large majority of cytosines observed in the 'C' lane of the genomic DNA sequence have been modified to thymidines following bisulfite treatment, as seen by comparing the 'TC' lanes from the genomic sequence with the 'TC' lanes from the cloned/converted template. Cytosine methylation was only detected at CpG dinucleotides as indicated by the closed circles marking the cytosines still present in the 'C' lanes from the various clones. We also detected clone-specific methylation differences at the site of individual CpG dinucleotides as indicated by the open circles in Figure 1 which show that two CpGs in these particular clones are variably methylated. PCR product was amplified from the bisulfite-converted placental DNA, cloned into pCRII-TA cloning vector and individual positive clones were identified and sequenced. The number of CpGs and cytosines occurring as individual cytosine residues are given for each exon, as are the number of clones analyzed and the total number of CpG and non-CpG cytosines evaluated. The number and frequency of methylated CpGs and non-CpG cytosines are also presented.
Similar results were observed in experiments using template amplified from bisulfite-converted exon 29. Ten CpG dinucleotides and 83 non-CpG cytosines were evaluated in each clone (Fig. 2) . As before, cytosine methylation was primarily observed at CpG dinucleotides, with three of these sites displaying variable methylation among the clones analyzed. Methylation at sites other than at CpGs was rarely observed and in fact occurred in less than 1% of all cytosines analyzed (Table 1) . Such methylation patterns were never seen at identical sites between individual clones, although two non-CpG cytosines within exon 29 where methylation was detected were located within separate -GCACmotifs ( Fig. 2: arrowheads) . Reports in the literature have described the occurrence of non-CpG methylation at CpNpG trinucleotides, where DNA methylation does occur, but at frequencies much less than at CpG motifs (14) . We were unable to observe DNA methylation at any of the 30 CpNpG sites accessible within the NF1 sequences we analyzed.
Two CpG dinucleotides and 23 non-CpG cytosines were evaluated in each exon 31 clone (Fig. 3) . As in the other exons, methylation was restricted to the cytosines present within CpG dinucleotides. Of particular interest to us in this study was the methylation status of CpG dinucleotides where mutational events in the NF1 gene have been previously described. For this study, we specifically chose to analyze the CpG dinucleotide located at position 5839 in exon 31. This is the site of the most common NF1 mutation, having been characterized in at least eight unrelated patients (10) . We found that the CpG located at this NF1 mutational hotspot was methylated in all clones analyzed, irrespective of tissue origin. This cytosine may provide an example of invariant methylation at an individual CpG dinucleotide.
DISCUSSION
We have established that DNA methylation is a common phenomenon occurring within at least three NF1 exons and which may extend through the length of the NF1 coding region. Nearly all methylation in these exons occurs at cytosines located within CpG dinucleotides. Table 1 shows that on placental DNA template, 92% (20/27) of the CpGs analyzed contained a methylated cytosine. Of the 1835 cytosines analyzed that were not contained within CpGs, only nine (less than 0.5%) were found to be methylated. Similar and consistent patterns of DNA methylation limited to CpG dinucleotides were also seen with human sperm DNA (data not shown). As with placental DNA, a large percentage of CpGs in these three exons were found to be methylated on the sperm DNA template, and very few other non-CpG cytosines were seen to be modified. These data form the basis of work currently underway to thoroughly assess tissuespecific methylation patterns and CpG methylation at other mutation sites within the NF1 gene. This paper demonstrates the use of a novel yet under-utilized technique that permits cytosine methylation analysis along continuous stretches of DNA. Previously, the technical limitations of Southern blotting and PCR-based methods restricted the analysis to those few DNA sub-sequences that were accessible to methylationsensitive restriction enzymes. Cloning the bisulfite-converted template prior to DNA sequencing as we have done is a more laborious procedure than direct sequencing alone. But as our results show, this cloning step yields data which is much more informative, since it allows CpG methylation on individual DNA strands to be assessed. As a result, we have been able to show that methylation appears to be a highly frequent phenomenon at CpG sites within the NF1 gene, including the mutational hotspot in exon 31.
Our results strengthen the hypothesis that methylatable CpGs in the NF1 gene may contribute to spontaneous mutations associated with this gene by showing that DNA methylation does occur at the majority of CpGs contained within these representative NF1 exons and at the common NF1 mutational hotspot (6) . An intriguing aspect of our data is that DNA methylation may account for one of the biological mechanisms responsible for the high mutation rate seen in the NF1 gene. It has been estimated that up to half of NF1 cases are the result of new mutations in the NF1 gene (7). At least two reports (9, 27) suggest that it is the paternal allele on which these sporadic mutations are occurring. The data presented in this paper show that CpG methylation is a consistent feature on sperm DNA and as such, these specifically methylated CpG dinucleotides may provide a hypermutable template on which transitional mutations could occur as germline mutations. Likewise, somatic mutations at methylated CpGs may be responsible for germline or somatic mosaicism. Interestingly, at least two of the patients known to carry the C5839T mutation are described as being sporadic cases of NF1 (15, 16) . While the parental origin of the alleles on which these mutations have occurred has not been reported, our hypothesis would suggest that they are likely to be paternal in origin.
Methylation-dependent transitional mutations at CpG dinucleotides in sperm DNA may be one source of paternally derived mutational events which are maintained in the genome following cytosine deamination and DNA replication (17) . In addition to the methylation hypothesis presented above, it is also likely that other molecular mechanisms may be responsible for generating sporadic mutations in the NF1 gene. Recently, several reports (18) (19) (20) describe patients with large NF1 deletions that are maternal in origin and therefore not associated with mutational changes on the paternal allele. These maternally-derived large deletions may not involve methylation per se but may be linked to other intrinsic features of the DNA sequence environment within which the mutations have occurred. These features might include the involvement of repeat elements and homonucleotide sequences that contribute to the high frequency of recombination events known to occur in female genomes (21, 22) .
It is apparent that the substantial successes of many research groups in identifying and characterizing mutations in the NF1 gene now permit further studies on the specific mechanisms responsible for NF1 mutagenesis in somatic and germline tissues and during early embryonic development. As well, the mechanisms responsible for second-hit mutation in NF1 tumours can begin to be addressed. By continuing to unravel the contribution of epigenetic phenomena such as DNA methylation to complex processes of mutagenesis, a clearer understanding of the molecular etiology of neurofibromatosis is beginning to be realized.
MATERIALS AND METHODS
Total genomic DNA from human placenta and sperm was isolated (23) and modified using the sodium bisulfite conversion protocol (11, 12) . Briefly, 10 µg of genomic DNA was digested with EcoRI for 6 h at 37_C and subsequently denatured with fresh 1 M NaOH (final concentration: 0.3 M) at 37_C for 15 min. The denatured template was then treated with 3.6 M NaHSO 3 (pH 5), and 100 mM hydroquinone, (to a final concentration of 3.1 M and 0.5 mM, respectively) and incubated at 55_C for 16 h under mineral oil. This incubation included 5 min soak periods at 94_C every 3 h to ensure that the template remained denatured (11, 13) . Following this treatment, the template was desalted with the Wizard DNA cleanup system (Promega) and treated with 1 M NaOH (37_C for 15 min) to remove the remaining bisulfite. The DNA was precipitated with 6 M ammonium acetate (pH 7) and 2 volumes of 95% ethanol, then the pellet was washed in 75% ethanol and dissolved in 50 µl double distilled H 2 O.
In the subsequent PCR amplifications, specific primers were constructed to amplify the sense-strand of the bisulfite-converted genomic DNA for NF1 exons 28, 29 and 31:
primer T28Sfor: 5′-TTAGGTTTAAAATTGGTTAAATTAATGGTG -3′ primer T28Srev: 5′-TTCATACTCTATATACTCAACCAATTTCCC -3′ primer T29Sfor: 5′-TTATTATTTTTTAGGTTGGTTTTATTGTTG -3′ primer T29Srev: 5′-AAAAACTATTTTAAAATTCATTAAATAATC -3′ primer T31Sfor: 5′-AGGTATTGAATTGAAATATTTTTGTTTGG -3′ primer T31Srev: 5′-ACAAACTCAATACCTACCCAAAACTTCCCC -3′
These primers amplified fragments of 335 bp, 424 bp and 209 bp which included all or most of the NF1 coding region contained within exons 28, 29 and 31 respectively. PCR was performed in 50 µl reactions containing 50-150 ng bisulfite-treated genomic DNA. Amplification conditions were: 5 cycles at 94_C (1 min), 55_C (2 min), 72_C (3 min) followed by 25 cycles at 94_C (1 min), 55_C (2 min), 72_C (1 min). A final 16 min soak (72_C) was also performed.
The PCR product was then cloned into pCRII TA cloning vector (TA Cloning system; Invitrogen, San Diego, CA). Individual positive clones were identified and plasmid DNA was isolated by alkaline lysis (23) and sequenced with the T7 sequencing system using the pFOR primer (Pharmacia). At least 10 clones were sequenced for each exon and each tissue to allow the methylation status of all cytosine residues, including those within CpG dinucleotides to be determined. Cytosines present in CpGs and as isolated cytosine residues were each scored. Specifically we analysed 6, 10 and 2 CpG dinucleotides in each clone amplified from exons 28, 29 and 31 respectively. Bisulfiteconverted template was compared with unconverted genomic DNA to allow the methylation status of all cytosines to be determined. Unmethylated cytosines were characterized as those bands that were absent in the 'C' lane and present in the 'T' lane of the reactions from converted template. Any bands in the 'C' lane of the sequenced converted DNA would indicate methylated cytosines which were subsequently amplified as cytosines.
